H. Lee Moffitt Cancer Center & Research Institute Signs Licensing Agreement with Proteacel, LLC

TAMPA, Fla.--(BUSINESS WIRE)--Moffitt Cancer Center and Proteacel LLC announced today that they have entered a licensing agreement under which Proteacel has acquired the exclusive rights to the PORE™ technology for delivery of genes into cells.